Definition of high-performance membranes - From the clinical point of view

Contributions to Nephrology

Volumn 173, Issue , 2011, Pages 1-10

  Saito, Akira ^a,b  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Yokohama Daiichi Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; ETHYLENE VINYL ALCOHOL COPOLYMER; ETHYLENE-VINYL ALCOHOL COPOLYMER; PLASMA PROTEIN; POLYVINYL DERIVATIVE; SERUM ALBUMIN;

ANEMIA; ARTICLE; ARTIFICIAL MEMBRANE; CHEMISTRY; CLINICAL TRIAL (TOPIC); FORECASTING; HEMOFILTRATION; HUMAN; INSTRUMENTATION; JAPAN; MATERIALS TESTING; METABOLISM; MOLECULAR WEIGHT; RENAL REPLACEMENT THERAPY; UREMIA;

ANEMIA; BIOCOMPATIBLE MATERIALS; BLOOD PROTEINS; CLINICAL TRIALS AS TOPIC; FORECASTING; HEMOFILTRATION; HUMANS; JAPAN; MATERIALS TESTING; MEMBRANES, ARTIFICIAL; MOLECULAR WEIGHT; POLYVINYLS; RENAL DIALYSIS; SERUM ALBUMIN; UREMIA;

EID: 80052072680     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000328938     Document Type: Article

References (29)

1. Kiil F: Development of a parallel-flow artificial kidney in plastics. Acta Chir Scand 1960;253(suppl):142-150.
2. Babb AL, Popovich R P, Christopher TG, Scribner BH: The genesis of the square meter-hour hypothesis. Trans Am Soc Artif Intern Organs 1971;7:81-86.
3. Babb AL, Farrell PC, Uvelli DA, Scribner BH: Hemodialyzer evaluation by examination of solute molecular spectra. Trans Am Soc Artif Intern Organs 1972;18:98-101.
4. Craddock PR, Fehr J, Dalmasso A P, Brighan KL, Jacob HS: Hemodialysis leucopenia: pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes. J Clin Invest 1977;59:879-888.
5. Chenoweth DE: Complement activation during hemodialysis: clinical observations, proposed mechanisms and theoretical implications. Artif Organs 1984;8:281-287.
6. Statistics Committee of the Japanese Society of Dialysis Therapy: Illustration. Present status of maintenance dialysis in Japan on December 31, 2008 (in Japanese). J Jap Soc Dial Ther 2009:30-38.
7. Kolff WJ, Wàtschinger B: Further development of a coil kidney. Disposable artificial kidney. J Lab Clin Med 1956;47:969-977.
8. Sato T, Saito A, Naito H, Yamagami S, Akizawa T, Akiba T, Takezawa S: Function and adaptation of blood purification methods. Evaluation methods and functional classification of dialyzers and hemofilters (in Japanese). J Jap Soc Dial Ther 1996;29:1231-1245.
9. Henderson LW, Livoti LG, Ford CA, Kelly AB, Lysaght MJ: Clinical experience with intermittent hemodiafiltrations. Trans Am Soc Artif Intern Organs 1973;19:119-123.
10. Henderson LW, Silverstein ME, Ford CA, Lysaght MJ: Clinical response to maintenance hemodiafiltration. Kidney Int 1975;7(suppl):58-62.
11. Quellhorst E, Rieger J, Doht B: Treatment of chronic uremia by an ultrafiltration kidney-first clinical experience. Proc Eur Dial Transplant Assoc 1976;13:314-317.
12. Lowrie EG, Laird NM, Parker TF, Sargent JA: Effect of the hemodialysis prescription on patient morbidity: report from the National Cooperative Dialysis Study. N Engl J Med 1981;305:1176-1181.
13. Gotch F, Sargent JA: A mechanistic analysis of the National Cooperative Dialysis Study. Kidney Int 1985;28:526-534.
14. Leber PD, Marsh DJ: Micropuncture study of concentration and fate of albumin in rat nephron. Am J Physiol 1970;219:358-363.
15. Saito A, Chung TG, Kanazawa I, Oda O, Ohta K: Clinical evaluation of protein permeating hemofilter and analysis of middle molecules in ultrafiltrate (in Japanese). Jinkou-Zouki 1981;10:907-911.
16. Saito A, Chung TG, Kanazawa I, Ogawa H, Ohta K: Middle and large molecule removal of protein-permeating hemodiafiltration; in Piskin E, Chang TMS (eds): Proc 4th Int Symp Hemoperfusion Artif Organs. Ankara, Turkish Artificial Organs Society, 1982, pp 42-46.
17. Saito A, Ogawa H, Takagi H, Chung TG: Clinical effects of large molecule removal by protein-permeable hemofilters (in Japanese). Jin to Touseki 1983;15:767-772.
18. Saito A, Ogawa H, Takagi H, Chung TG: Clinical evaluation of protein-permeating hemodiafiltration (in Japanese). Jinkou-Zouki 1984;13:643-646.
19. Saito A, Naito H, Hirohata M: Dialytic removal of middle molecules and low molecular weight proteins; in Atsumi K, Maekawa M, Ota K (eds): Progress in Artificial Organs. Cleveland, ISAO Press, 1984, pp 412-416.
20. Saito A, Ogawa H, Chung TG, Maeda K: CAPD and protein-permeating hemodialysis: a clinical comparison; in Maher JF, Winchester JF (eds): Frontiers in Peritoneal Dialysis. New York, Field, Rich & Assoc Inc, 1986, pp 307-311.
21. Saito A, Ogawa H, Tkagi H, Ohta K, Akasu H, Kawai S, Kubotsu A: A new approach to glomerular filtration. Trans Am Soc Artif Intern Organs 1983;29:673-677.
22. 2-microglobulin. Biochem Biophys Res Commun 1985, 129:701-706.
23. Saito A, Suzuki I, Chung TG, Ogawa, Ohta K: Separation of an inhibitor of erythropoiesis in 'middle molecules' from hemodialysate from patients with chronic renal failure. Clin Chem 1986;32:1938-1941.
24. Saito A, Takagi T, Chung TG, Ohta K: Serum levels of polyamines in patients with chronic renal failure. Kidney Int 1983;24(suppl 16):S234-S237.
25. Takagi T, Taoka M, Sakurai K, Ogawa H, Saito A: Removal of low molecular weight proteins by hemodialysis with several kinds of high-performance membrane dialyzers (in Japanese). Jin to Touseki 1987;86(suppl):8-11.
26. Saito A, Yamamoto Y, Maeda K, Kobayashi K, Ohta K: Abnormal conformation of albumin in uremia. Proc Eur Dial Transpl Assoc 1978;15:628-629.
27. Saito A: Conformational change of albumin in uremia (in Japanese). Rinsho-Kagaku 1979;7:249-254.
28. Koda Y, Nishi S, Miyazaki S, Haginoshita S, Sakurabayashi T, Suzuki M, Sakai S, Yuasa Y, Hirasawa Y, Nishi T: Switch from conventional to high-flux membrane reduces the risk of carpal tunnel syndrome and mortality of hemodialysis patients. Kidney Int 1997;52:1096-1101.
29. Schwalbe S, Holzhauer M, Schaeffer J, Galanski M, Koch KM, Floege J: Beta-2-microglobulin-associated amyloidosis: a vanishing complication of long-term hemodialysis? Kidney Int 1997;52:1077-1083.